Menu Search
Equities

Eli Lilly and Co

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LLY:STU

Eli Lilly and Co

Actions
  • Price (EUR)875.40
  • Today's Change-4.90 / -0.56%
  • Shares traded74.00
  • 1 Year change+6.74%
  • Beta0.3988
Data delayed at least 15 minutes, as of Feb 17 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Eli Lilly and Co grew revenues 44.70% from 45.04bn to 65.18bn while net income improved 94.90% from 10.59bn to 20.64bn.
Gross margin83.04%
Net profit margin31.67%
Operating margin40.35%
Return on assets21.59%
Return on equity101.36%
Return on investment32.37%
More ▼

Cash flow in USDView more

In 2025, Eli Lilly and Co increased its cash reserves by 122.40%, or 4.00bn. The company earned 16.81bn from its operations for a Cash Flow Margin of 25.80%. In addition the company used 10.97bn on investing activities and also paid 2.21bn in financing cash flows.
Cash flow per share25.17
Price/Cash flow per share43.18
Book value per share28.09
Tangible book value per share14.94
More ▼

Balance sheet in USDView more

Eli Lilly and Co has a Debt to Total Capital ratio of 61.57%, a lower figure than the previous year's 201.01%.
Current ratio1.58
Quick ratio1.19
Total debt/total equity1.60
Total debt/total capital0.6157
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)0.75%
Div growth rate (5 year)15.18%
Payout ratio (TTM)27.06%
EPS growth(5 years)27.59
EPS (TTM) vs
TTM 1 year ago		95.90
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.